Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Pharmaxis.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Health & Biotech
Move over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalysts
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but don’t throw the baby out with the bathwater
Health & Biotech
ASX Health Stocks: Cannabis stock Little Green Pharma awarded French trial tender for CBD50
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Health & Biotech
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
News
CLOSING BELL: A crazy ride for tech stocks and Wildcat as the ASX dips 0.22%
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
Health & Biotech
ASX Health Stocks: Pharmaxis and Aroa lift on FDA news, Cynata to commence Phase 2 trial
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
News
Trading Places: Rinehart makes play for Warrego Energy, Whitehaven gets new substantial shareholder
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rattling the tin, Telix shares soar ~26% on positive quarterly results
Health & Biotech
Clinical Trials 101: How to spot a clinical trial with a strong chance of getting a drug to market
Health & Biotech
